1. Snyder CH. Visceral larva migrans. ten years' experience. Pediatrics. 1961. 28:85–91.
2. Schantz PM, Glickman LT. Toxocaral visceral larva migrans. N Engl J Med. 1978. 298:436–439.
Article
3. Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol. 2001. 39:1–11.
Article
4. Glickman LT, Schantz PM. Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiol Rev. 1981. 3:230–250.
Article
5. Sturchler D, Weiss N, Gassner M. Transmission of toxocariasis. J Infect Dis. 1990. 162:571.
Article
6. Nagakura K, Tachibana H, Kaneda Y, Keto Y. Toxocariasis possibly caused by ingesting raw chicken. J infect Dis. 1989. 160:735–736.
Article
7. Obweller A, Jensen-Jarolim E, Auer H, Huber A, Kraft D, Aspock H. Toxocara infections in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexes. Parasite Immunol. 1998. 20:311–317.
8. Park HY, Lee SU, Huh S, Kong Y, Magnaval JF. A seroepidemiological survey for toxocariasis in apparently healthy residents in Gwangwon-do, Korea. Korean J Parasitol. 2002. 40:113–117.
Article
9. Kwon NH, Oh MJ, Lee SP, Lee BJ, Choi DC. The Clinical impact of toxocariasis in patients with unknown eosinophilia. Korean J Asthma Allergy Clin Immunol. 2005. 25:299–304.
10. Magnaval JF, Fabre R, Maurieres P, Charlet JP, de Larrard B. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res. 1991. 77:697–702.
Article
11. Magnaval JF, Fabre R, Maurieres P, Charlet JP, de Larrard B. Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and posttreatment follow-up of human toxocariasis. J Clin Microbiol. 1992. 30:2269–2274.
Article
12. Yoshikawa M, Nishiofuku M, Moriya K, Ouji Y, Ishizaka S, Kasahara K, et al. A familial case of visceral toxocariasis due to consumption of raw bovine liver. Parasitol Int. 2008. 57:525–529.
Article
13. Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxicariasis. Parasitolotgy. 1995. 110:529–533.
Article
14. Lim YH, Lee BJ, Lee SP, Jang SI, Kang SY, Choi DC. Comparison between steroid alone and steroid/albendazole combination therapy in human toxocariasis with eosinophilia. J Asthma Allergy Clin Immunol. 2001. 21:427. (abstract).
15. Despommier D. Toxacariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003. 16:265–272.
Article
16. Sturchler D, Schubarth P, Gualzata M, Gottstein B, Oettli A. Thiabendazole vs albndazole in treatment of toxocariasis; a clinical trial. Ann Trop Med Parasitol. 1989. 83:473–478.
17. Hossack J, Ricketts P, Te HS, Hart J. A case of adult hepatic toxocariasis. Nat Clin Pract Gastroenterol Hepatol. 2008. 5:344–348.
Article
18. Matsuki Y, Fujii T, Nakamura-Uchiyama F, Hiromatsu K, Nawa Y, Hayashi T, et al. Toxocariasis presenting with multiple effusions in the pericardial space, thoracic cavity, and Morrison's pouch. Intern Med. 2007. 46:913–914.
Article